IDEXX Labs (IDXX) Tops Q3 EPS by 27c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts IDXX Hot Sheet
Join SI Premium – FREE
IDEXX Labs (NASDAQ: IDXX) reported Q3 EPS of $1.69, $0.27 better than the analyst estimate of $1.42. Revenue for the quarter came in at $722 million versus the consensus estimate of $669.45 million.
For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Uber Q3 profit, revenue beat estimates as gross bookings jump 20%
- Harmony Biosciences (HRMY) Misses Q3 EPS by 30c; Offers Guidance
- IDEXX Laboratories (IDXX) PT Raised to $810 at Morgan Stanley
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
